Navigation Links
Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib
Date:9/2/2008

on, visit the company's website at http://www.volcanocorp.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release regarding Volcano's business that are not historical facts may be considered forward-looking statements, including statements regarding the ability of VH(R) IVUS to measure the effects of investigational compounds, the ability to identify and characterize composition and to define patient strategy to improve patient outcomes. Forward-looking statements involve risks and uncertainties and are based on management's current expectations. Actual results could differ materially from these forward-looking statements as a result of certain factors, including the risks and uncertainties related to the results of clinical studies and other factors discussed in Volcano's filings with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, which speak only as of the time they are made. Volcano undertakes no obligation to update any forward-looking statements to reflect new information, events or circumstances, changed assumptions or otherwise. Actual results or experience could differ materially from the forward-looking statements.


'/>"/>
SOURCE Volcano Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology
2. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
3. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
4. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
5. First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology Receives Regulatory Approval
6. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
7. Wacker Validates Scalability of Anticalin(R) Production With E.coli Secretion Technology and Will Produce Pieris First Clinical Candidate PRS-050
8. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
9. Modigene Platform Validated in Independent Phase III Trial of CTP Technology
10. Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology
11. GeoVax Reports Progress on Its AIDS Vaccine Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...v. 19 Alexza Pharmaceuti...ts corporate presentation will be webcast live dur...erence on Wednesday, December 2, 2009 at 9:00 a.m....rom The New York Palace Hotel in New York and will...and CEO. ,, To access the live presentation v...
(Date:11/19/2009)...19 The D e al magazi...ost Admired Corporate Dealmakers for the second co...Most Admired Dealmaker in pharma/biotech for the m...vestitures since January 2006. ,, Over the past...o with a focus on high-growth, innovation-driven b...
(Date:11/19/2009)...ewswire/ -- As the seasons change, another season ...n preparing yourself. ,, Listen to this report ... ,, http://inr.mediaseed.tv/oneClip_C/?feed=...k is a division of The NewsMarket. Registered jou...nd photos at http://www.thenewsmarket.com . ,...
Breaking Medicine Technology:Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3Hangovers May Be Tougher for Migraine Sufferers 59737 1Evosys a Major Player in the Oracle E Business Suite Implementation Support and Consultancy Services Domain has Recently Been Awarded Oracles Certi 59733 1Evosys a Major Player in the Oracle E Business Suite Implementation Support and Consultancy Services Domain has Recently Been Awarded Oracles Certi 59733 2Evosys a Major Player in the Oracle E Business Suite Implementation Support and Consultancy Services Domain has Recently Been Awarded Oracles Certi 59733 3PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 1PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 2PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 3PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 4
..., Nov. 21 Commenting on a study,of lung transplan...g,pediatric pulmonologist calls the study "startli...rnal of Medicine that accompanies the study., Jul... Endowed Chair in,Pediatric Pulmonary Medicine at ...he study by a University of Utah research team, wh...
...Nov. 20 The following statement,was released toda...man of,the Committee for Pro-Life Activities at th..."Studies published this week in the journals Cell ... research and therapies while fully respecting,the... Wisconsin used four genes to ,reprogram,ordinary ...
Other Medicine Technology:Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis 2Stem Cell Breakthrough Advances Science Without 'Ethical Landmines,' Says Cardinal 2
(Date:11/20/2009).... 20 /PRNewswire-FirstCall/ - NUCRYST Pharmaceutic...f Shareholders will be held on Monday, December 21...approval of two special resolutions. The first spe...le of all or substantially all of the assets of NU...the asset purchase agreement dated November 10, 20...
(Date:11/20/2009)...tors and Congressmen in Competitive Re-election Ba...ote , Washington, DC (Voc...running for re-election next year in races deemed ...may come to regret voting for House Speaker Nancy ...eaking Zogby International/ O’Leary Report ...
(Date:11/20/2009)...l, November 20 Cardio Va....CVSLMEDICAL.COM , a leading,developer of advanced...d that,the company,s Board of Directors has decide...a and the Far East for its proprietary next-genera...oplasty (PCTA) procedures. , Cardio Vascu...
(Date:11/20/2009)...e November 20 in the Journal of the National Canc...hopes that often appear in news coverage of cancer...h the media and journals to help alleviate the pro... Woloshin, M.D., M.S., of Center for Medicine and ...licy and Clinical Practice in New Hampshire, and B...
(Date:11/20/2009)...d out of Dallas, TX, the new addition to blue sky ...are made in the USA. , Au...ubs is an independent medical scrubs brand which f...n and distribution of hospital uniforms and surgic...cts via their online boutique, the Austin, TX busi...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Blue Sky Scrubs Secures a Second Texas Manufacturer 2
...a severe form of arterial disease appear to have l...of their diet or smoking habits. Peripheral ar... condition in which fatty build-up accumulates ins...ted with an increased risk of death and disability...
...ents with heart disease are twice as likely to hav... with medication, research suggests. Researchers i... age of 80 who suffered from chronic angina. ...inserted and the balloon inflated to widen the art...
...e often means that areas of the heart muscle becom...th painful angina attacks, and to heart attacks. I...nforce the supply to the heart muscle, this could ...or take months to do so. // Altering a gene...
... a new study obesity does not worsen the outcome i...t failure, experience many problems. Generally in ...e body as efficiently as it should. Even though th... have surveyed 1000 people with heart failure and ...
...has found that the risk of developing a blood clot...ased with the duration of air travel.Like deep vei...clots that are believed to be associated with long...ing care// on arrival at France's busiest internat...
...rugs like it could be making healthy people with n...is prescribed to more than 38 million people world...stries biggest success stories of recent years. Pr...known were hailed as "wonder drugs" when they firs...
Other Medicine News:Health News:Wonder drug - could end in disaster 2
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: